|
Mutation Information
|
Mutation Site
|
T334A |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
Gp120 |
|
Country
|
US |
Literature Information
|
PubMed PMID
|
32156815
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2020 |
|
Journal
|
mBio |
|
Title
|
Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants. |
|
Author
|
Martinez DR,Tu JJ,Kumar A,Mangold JF,Mangan RJ,Goswami R,Giorgi EE,Chen J,Mengual M,Douglas AO,Heimsath H,Saunders KO,Nicely NI,Eudailey J,Hernandez G,Morgan-Asiedu PK,Wiehe K,Haynes BF,Moody MA,LaBranche C,Montefiori DC,Gao F,Permar SR |
|
Evidence
|
Notably, N332 V3 glycan neutralization-resistant infant-T/F virus 9112 had a T334A mutation, which ablated the N332 glycosylation signature that is required for the glycan attachment at this site, whereas all of the neutralization-sensitive paired autologous maternal viruses had an intact N332 glycosylation signature.
|
|
|
HIV Mutation Detail Information